CMBA
CVS icon

C.M. Bidwell & Associates’s CVS Health CVS Stock Holding History

C.M. Bidwell & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46
Closed -$5K – 550
2021
Q4 		$5K Hold
46
– – ﹤0.01% 430
2021
Q3 		$4K Hold
46
– – ﹤0.01% 468
2021
Q2 		$4K Hold
46
– – ﹤0.01% 491
2021
Q1 		$3K Sell
46
-3,495
-99% -$255K ﹤0.01% 473
2020
Q4 		$242K Buy
3,541
+702
+25% +$45.7K 0.2% 79
2020
Q3 		$166K Sell
2,839
-1,328
-32% -$82.6K 0.15% 139
2020
Q2 		$271K Sell
4,167
-1,832
-31% -$115K 0.25% 97
2020
Q1 		$356K Buy
5,999
+2,598
+76% +$173K 0.38% 63
2019
Q4 		$253K Sell
3,401
-7,340
-68% -$515K 0.23% 91
2019
Q3 		$677K Buy
10,741
+10,695
+23,250% +$634K 0.67% 31
2019
Q2 		$3K Hold
46
– – ﹤0.01% 350
2019
Q1 		$2K Hold
46
– – ﹤0.01% 359
2018
Q4 		$3K Sell
46
-442
-91% -$33K ﹤0.01% 340
2018
Q3 		$38K Hold
488
– – 0.04% 253
2018
Q2 		$31K Buy
488
+460
+1,643% +$30.3K 0.03% 274
2018
Q1 		$2K Hold
28
– – ﹤0.01% 348
2017
Q4 		$2K Hold
28
– – ﹤0.01% 355
2017
Q3 		$2K Hold
28
– – ﹤0.01% 267
2017
Q2 		$2K Buy
+28
New +$2.21K ﹤0.01% 281
2015
Q4 		– Sell
-85,535
Closed -$8.25M – 242
2015
Q3 		$8.25M Buy
85,535
+35,400
+71% +$3.72M 2.03% 3
2015
Q2 		$5.26M Sell
50,135
-44,500
-47% -$4.55M 1.17% 21
2015
Q1 		$9.77M Buy
94,635
+52,825
+126% +$5.35M 2.16% 3
2014
Q4 		$4.03M Hold
41,810
– – 0.92% 48
2014
Q3 		$3.33M Sell
41,810
-73,265
-64% -$5.78M 0.78% 68
2014
Q2 		$8.67M Buy
115,075
+65,905
+134% +$4.98M 1.98% 3
2014
Q1 		$3.68M Sell
49,170
-66,770
-58% -$4.72M 0.88% 56
2013
Q4 		$8.3M Sell
115,940
-305
-0.3% -$19.6K 2.05% 5
2013
Q3 		$6.6M Buy
116,245
+175
+0.2% +$10.4K 1.82% 8
2013
Q2 		$6.64M Buy
+116,070
New +$6.72M 1.95% 4

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

C.M. Bidwell & Associates's CVS Position: Q1 2022 in Review

C.M. Bidwell & Associates sold out of CVS Health (CVS) in Q1 2022, closing a stake of 46 shares — an estimated $5K sold.

C.M. Bidwell & Associates first reported a position in CVS in Q2 2013 and held it in 29 quarters. The position peaked at $9.77M in Q1 2015. 2,366 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

  • C.M. Bidwell & Associates reported no remaining CVS Health position as of Q1 2022 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 46 CVS Health shares in Q1 2022, an estimated $5K.
  • C.M. Bidwell & Associates first reported a position in CVS Health in Q2 2013 and held it in 29 quarters.
  • C.M. Bidwell & Associates's CVS Health position peaked at $9.77M in Q1 2015.
  • 2,366 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.